tiprankstipranks
Trending News
More News >

TruScreen Group Ltd. Announces New Quotation of Securities

Story Highlights
  • TruScreen Group Ltd. is a medical technology company specializing in cervical cancer screening solutions.
  • The company is quoting 80,670,455 new securities on the ASX to boost its market presence.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
TruScreen Group Ltd. Announces New Quotation of Securities

Don’t Miss TipRanks’ Half-Year Sale

TruScreen Group Ltd. ( (AU:TRU) ) has provided an update.

TruScreen Group Ltd. has announced a new application for the quotation of securities, with a total of 80,670,455 ordinary fully paid foreign exempt securities to be quoted on the ASX. This move is expected to enhance the company’s financial flexibility and market presence, potentially impacting its operations and positioning within the medical technology industry.

More about TruScreen Group Ltd.

TruScreen Group Ltd. operates in the medical technology industry, focusing on developing and providing advanced cervical cancer screening solutions. The company is known for its innovative TruScreen device, which offers a real-time, non-invasive method for detecting cervical cancer, aiming to improve early diagnosis and treatment outcomes.

Average Trading Volume: 209,479

Technical Sentiment Signal: Sell

Current Market Cap: A$11.32M

For a thorough assessment of TRU stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1